JPY 1934.0
(-0.31%)
Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 788.13 Billion | 751.28 Billion | 445.45 Billion | 292.91 Billion | 238.86 Billion | 238.56 Billion |
Net Income | 321.7 Billion | 1412.44 Billion | 643.45 Billion | 67.39 Billion | 164.73 Billion | 494.04 Billion |
Depreciation & Amortization | 319.6 Billion | 301.52 Billion | 210.04 Billion | 180.85 Billion | 187.53 Billion | 113.65 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 66.98 Billion | -73.27 Billion | -85.02 Billion | 51.97 Billion | -55.25 Billion | -47.13 Billion |
Other non-cash items | 79.82 Billion | -889.41 Billion | -323.01 Billion | -7.3 Billion | 362.7 Billion | -322 Billion |
Investing Cash Flow | -308.32 Billion | -525.57 Billion | -130.72 Billion | -417.18 Billion | -242.69 Billion | -682 Billion |
Investments in PPE | -252.13 Billion | -196.66 Billion | -150.96 Billion | -138.88 Billion | -110.95 Billion | -319.4 Billion |
Acquisitions | 11.79 Billion | -31.41 Billion | 31.93 Billion | -47.69 Billion | 10.42 Billion | -263 Billion |
Investment purchases | -547.01 Billion | -256.21 Billion | -54.62 Billion | -99.75 Billion | -37.73 Billion | -386.01 Billion |
Sales/Maturities of investments | 339.55 Billion | 90.91 Billion | 37.35 Billion | 54.72 Billion | 3.15 Billion | 249.61 Billion |
Other Investing Activities | 139.47 Billion | -132.19 Billion | 5.57 Billion | -185.58 Billion | -107.58 Billion | 36.8 Billion |
Financing Cash Flow | -499.06 Billion | -241.92 Billion | -315.21 Billion | 126.74 Billion | -58.78 Billion | 405.18 Billion |
Debt repayment | -280.58 Billion | -217.58 Billion | -157.4 Billion | -158.9 Billion | -10.8 Billion | -76.18 Billion |
Dividends payments | -90.14 Billion | -80.39 Billion | -46.71 Billion | -43.79 Billion | -39.43 Billion | -26.29 Billion |
Common Stock Repurchased | -99.99 Billion | -121.19 Billion | -105.47 Billion | - | - | - |
Common Stock Issuance | - | - | -1.86 Billion | - | - | - |
Other Financing Activities | -8.21 Billion | 177.24 Billion | -3.74 Billion | 329.44 Billion | -8.55 Billion | 507.65 Billion |
Accounts receivables | 75.82 Billion | -52.4 Billion | -91.61 Billion | 71.72 Billion | -34.63 Billion | - |
Accounts payables | -28.88 Billion | 32.68 Billion | -3.72 Billion | -6.61 Billion | -10.39 Billion | - |
Inventory | 4.2 Billion | -16.14 Billion | -14.53 Billion | 6.5 Billion | -760 Million | -11.35 Billion |
Other working capital | 15.84 Billion | -37.4 Billion | 24.84 Billion | -19.65 Billion | -9.46 Billion | -35.77 Billion |
Cash at beginning of period | 95.02 Billion | 191.21 Billion | 172.4 Billion | 173.77 Billion | 276.08 Billion | 276.07 Billion |
Cash at end of period | 95.08 Billion | 211.65 Billion | 191.21 Billion | 172.4 Billion | 173.77 Billion | 239.65 Billion |
Capital Expenditure | -252.13 Billion | -196.66 Billion | -150.96 Billion | -138.88 Billion | -110.95 Billion | -319.4 Billion |
Effect of forex changes on cash | 7.58 Billion | 36.66 Billion | 19.29 Billion | -3.84 Billion | -406 Million | 1.82 Billion |
Net cash flow / Change in cash | 61 Million | 20.44 Billion | 18.8 Billion | -1.36 Billion | -102.3 Billion | -36.42 Billion |
Free Cash Flow | 535.99 Billion | 554.61 Billion | 294.48 Billion | 154.03 Billion | 127.9 Billion | -80.83 Billion |
Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 90.75 Billion | 121.83 Billion | 321.7 Billion | 41.31 Billion | 26.13 Billion | 319.24 Billion |
Depreciation & Amortization | 96.59 Billion | 92 Billion | 319.6 Billion | - | - | 51.22 Billion |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 45.56 Billion | -47.37 Billion | 66.98 Billion | - | - | -6.29 Billion |
Other non-cash items | 172.55 Billion | 205.73 Billion | 79.82 Billion | -41.31 Billion | -26.13 Billion | -64.59 Billion |
Investing Cash Flow | -194.6 Billion | -119.32 Billion | -308.32 Billion | - | - | -212.01 Billion |
Investments in PPE | -61.02 Billion | -59.11 Billion | -252.13 Billion | - | - | -31.12 Billion |
Acquisitions | -146 Million | -36.53 Billion | 11.79 Billion | - | - | 39.38 Billion |
Investment purchases | -215.58 Billion | -58.13 Billion | -547.01 Billion | - | - | -289.4 Billion |
Sales/Maturities of investments | 43.65 Billion | 70.24 Billion | 339.55 Billion | - | - | 38.13 Billion |
Other Investing Activities | 38.49 Billion | -35.77 Billion | 139.47 Billion | - | - | -10.72 Billion |
Financing Cash Flow | -44.19 Billion | -3.11 Billion | -499.06 Billion | - | - | -17.43 Billion |
Debt repayment | -2.99 Billion | -48.99 Billion | -280.58 Billion | - | - | -16.49 Billion |
Dividends payments | -10.21 Billion | -36.35 Billion | -90.14 Billion | - | - | -8.83 Billion |
Common Stock Repurchased | -24.99 Billion | - | -99.99 Billion | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -24 Million | -9.99 Billion | -8.21 Billion | - | - | 3.35 Billion |
Accounts receivables | 14.19 Billion | -57.41 Billion | 75.82 Billion | - | - | - |
Accounts payables | 1.37 Billion | 17.42 Billion | -28.88 Billion | - | - | - |
Inventory | 921 Million | -7.97 Billion | 4.2 Billion | - | - | -3.57 Billion |
Other working capital | 29.07 Billion | 579 Million | 15.84 Billion | - | - | - |
Cash at beginning of period | 227.31 Billion | 169.24 Billion | 95.02 Billion | - | - | 182.41 Billion |
Cash at end of period | 233.15 Billion | 227.31 Billion | 95.08 Billion | - | - | 154.84 Billion |
Capital Expenditure | -61.02 Billion | -59.11 Billion | -252.13 Billion | - | - | -31.12 Billion |
Effect of forex changes on cash | 15.88 Billion | 8.38 Billion | 7.58 Billion | - | - | 888 Million |
Net cash flow / Change in cash | 5.84 Billion | 58.07 Billion | 61 Million | - | - | -27.57 Billion |
Free Cash Flow | 167.74 Billion | 81.1 Billion | 535.99 Billion | - | - | 166.44 Billion |
AGD
SYME
ULNV
NOG
MREI
SQZ